A detailed history of Avantax Advisory Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 159,134 shares of ABT stock, worth $18.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
159,134
Previous 156,721 1.54%
Holding current value
$18.7 Million
Previous $16.3 Million 11.41%
% of portfolio
0.12%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $241,468 - $285,047
2,413 Added 1.54%
159,134 $18.1 Million
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $4.55 Million - $5.08 Million
45,186 Added 40.51%
156,721 $16.3 Million
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $37,893 - $41,852
-346 Reduced 0.31%
111,535 $12.7 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $96,503 - $118,128
1,070 Added 0.97%
111,881 $12.3 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $185,423 - $222,477
-1,941 Reduced 1.72%
110,811 $10.7 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $295,285 - $329,009
2,930 Added 2.67%
112,752 $12.3 Million
Q1 2023

Apr 28, 2023

BUY
$96.86 - $114.01 $492,920 - $580,196
5,089 Added 4.86%
109,822 $11.1 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $400,868 - $470,279
4,217 Added 4.2%
104,733 $11.5 Million
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $804,269 - $931,193
8,312 Added 9.01%
100,516 $9.73 Million
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $420,426 - $508,161
4,119 Added 4.68%
92,204 $10 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $1.1 Million - $1.35 Million
9,689 Added 12.36%
88,085 $10.4 Million
Q4 2021

Jan 24, 2022

BUY
$115.53 - $141.46 $964,097 - $1.18 Million
8,345 Added 11.91%
78,396 $11 Million
Q3 2021

Oct 21, 2021

BUY
$116.66 - $129.06 $1.29 Million - $1.43 Million
11,083 Added 18.79%
70,051 $8.28 Million
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $619,717 - $729,496
5,858 Added 11.03%
58,968 $6.84 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $896,188 - $1.06 Million
8,234 Added 18.35%
53,110 $6.37 Million
Q4 2020

Jan 22, 2021

SELL
$105.0 - $114.42 $4.77 Million - $5.2 Million
-45,419 Reduced 50.3%
44,876 $4.92 Million
Q3 2020

Oct 14, 2020

BUY
$91.64 - $111.29 $5.22 Million - $6.34 Million
56,992 Added 171.13%
90,295 $9.83 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $769,145 - $984,410
10,045 Added 43.19%
33,303 $3.04 Million
Q1 2020

Apr 30, 2020

SELL
$62.82 - $91.86 $635,864 - $929,806
-10,122 Reduced 30.32%
23,258 $1.84 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $554,987 - $617,830
7,069 Added 26.87%
33,380 $2.9 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $259,269 - $281,128
3,168 Added 13.69%
26,311 $2.21 Million
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $88,913 - $103,700
1,220 Added 5.56%
23,143 $1.95 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $60,326 - $72,934
911 Added 4.34%
21,923 $1.75 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $1.38 Million - $1.56 Million
21,012 New
21,012 $1.52 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.